- Rating
- 1
- Confidence
- 4
- Informativeness
- 1
- Presentation
- 1
- Soundness
- 1
Read review
Paper summary
The paper shows that patch selection in WSI analysis often fails to reduce compute when selection occurs after high-resolution feature extraction. To address this, it proposes a coarse-to-fine cascade: a frozen thumbnail encoder first screens candidate regions, a frozen pathology foundation model reranks survivors at coarse resolution, and only the final selected regions are encoded at fine resolution for MIL prediction. The method aims to reduce fine-resolution encoder evaluations while preserving slide-level classification and survival performance across CAMELYON16 and TCGA datasets.
Critical strengths
- The proposed cascade is simple. It uses cheap thumbnail screening before coarse pathology reranking and reserves expensive fine-resolution encoding only for selected regions.
Critical weaknesses
-
The novelty is somewhat limited. The main observation that patch-selection cost depends on where selection is performed is intuitive, and coarse-to-fine WSI inference has been explored in prior work such as ZoomMIL, HDMIL, WISE-FUSE, and multiscale DSMIL. The main contribution is clearer compute accounting plus an engineering combination of thumbnail screening, coarse reranking, and distillation. The title’s claim that patch selection “rarely saves compute” also seems overly broad, since not all patch-selection methods perform selection after full 20× encoding.
-
The claim of preserved performance is not uniformly supported. The CAMELYON16 task shows a clearer gap: the cascade is below full-bag encoding and also below some published selection baselines. For survival prediction, the standard errors are large, and cascade variants are often slightly below their full-bag counterparts.
-
The paper should better justify the practical importance of compute reduction relative to accuracy. In pathology, users may prefer a slower but more accurate full-bag model, especially for high-stakes diagnosis.
-
Since the method already encodes all candidate regions at 5× during training, the paper should report how well an MIL model performs using all 5× features directly, without any 20× encoding. If this baseline is competitive, the necessity of the full three-stage cascade would be less clear. The comparison with published methods also needs more detail about whether the same encoder, tiling, preprocessing, and compute accounting are used.
-
Several Table 3 results are counterintuitive and need deeper explanation. The tumor oracle performs only slightly better than random selection on CAMELYON16. Similarly, 20× fine-resolution selection performs worse than the cascade despite using more detailed features. These results may indicate issues with the oracle setup, negative-slide handling, optimization, or variance, but the current explanation is not fully convincing.
-
The method depends on manually chosen budgets such as K=500 and b=10. The sensitivity analysis shows that too small a K can substantially hurt CAMELYON16 performance, so the compute–accuracy tradeoff appears task-dependent and may require tuning.
-
The evaluation is limited to public CAMELYON16 and TCGA datasets. Since the method discards most tissue before prediction, stronger cross-institution validation would be important.
-
The writing and presentation need improvement. The paper has several grammar issues and dense explanations that make the method and experimental protocol harder to follow. Clearer writing, more precise terminology, and better separation between motivation, method, and ablation analysis would improve readability.
Questions for authors
-
Can the authors clarify the novelty relative to prior coarse-to-fine WSI methods? The title’s claim that patch selection “rarely saves compute” also seems broad, since some prior methods already perform coarse-to-fine selection.
-
Can the authors justify the practical importance of compute reduction in pathology settings where users may prefer a slower but more accurate model, especially for high-stakes diagnosis?
-
Can the authors add a low-cost baseline using all 5× features directly, without any 20× encoding? Since the method already encodes all candidate regions at 5× during training, this baseline would clarify whether the full three-stage cascade is necessary.
-
Can the authors explain the counterintuitive Table 3 results, especially why the tumor oracle is only slightly better than random selection and why 20× fine-resolution selection performs worse than the cascade?
-
Can the authors provide more sensitivity analysis for K and b?
-
Can the authors discuss robustness beyond CAMELYON16 and TCGA, preferably with cross-institution validation?